4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000004
CEO & President sold 4,986 shares at $26.28 ($131,032)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-13 | Sale : show line 1 in the form 10b5-1 | −4,986 | $26.28 | $131,032 | 363,165 | D |
| Open-market sales · 4,986 sh · avg $26.28 · $131,032 | ||||||
Loading xslF345X06/ownership.xml…